Elliott S. Lichtstein, MD
- Specialties
-
Interventional CardiologyCardiology
- Gender
-
Male
- Languages
-
English
Location(s)
VMG Cardiology, Westwood
333 Old Hook Road
Suite 200
Westwood, NJ 07675
Phone: 201-664-0201
Fax: 201-666-7970
VMG Cardiology, Westwood
20 Prospect Avenue
Suite #810
Hackensack, NJ 07601
Phone: 201-342-7727
Fax: 201-342-2422
Education
- Education
-
MD, Temple University School Of Medicine, 1977 - 1981
BA, Univ Of Rochester School Of Medicine, 1974 - 1977
- Fellowships
-
Long Island Jewish-Hillside Medical Center, Cardiology, 1984 - 1986
- Internship & Residency
-
Albany Medical Center, Internal Medicine, 1981 - 1984
- Board Certifications
-
American Board Of Internal Medicine - Certified, 1984
Subspecialty Board Of Cardiovascular Disease - Certified, 1987
Get to Know Me
What are some of the specific conditions you treat?
Coronary artery disease, myocardial infarction, atrial fibrillation, congestive heart failure, palpitations, hypertension, arrhythmias, pacemaker management, edema, aortic valve disease, mitral valve disease, mitral valve prolapse, aortic aneurysm, PAD-peripheral artery disease, lipid disorders, elevated cholesterol.
What techniques or procedures do you use in your practice?
We care for our patients with the latest techniques in cardiac diagnosis including noninvasive and invasive modalities.
Describe some of your professional highlights.
- Fellow of the American College of Cardiology.
- Board certified in internal medicine, cardiovascular diseases.
- Board certified in invasive cardiology.
Publications & Research
Clinical Trials
Fourier
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease.
Odyssey
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome.
Cardiovascular Inflammation Reduction Trial (CIRT)
The Cardiovascular Inflammation Reduction Trial (CIRT) is a randomized clinical trial investigating whether taking low-dose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages. This trial is funded by the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH).
Insurance
Valley Medical Group providers accept the following plans.
Patient Ratings & Comments
Comments are gathered from our patient satisfaction surveys.